In the last decade, the detection of human papillomaviruses (HPV) has become increasingly
important in cervical cancer screening and the treatment of cancer precursors. HPV …

Objectives To estimate long‐term cervical intraepithelial neoplasia grade 3 (CIN3) risks
associated with different triage strategies for human papillomavirus positive (HPV+) women …

Abstract Background Primary Human Papilloma Virus (HPV) testing is the currently
recommended cervical cancer (CxCa) screening strategy by the Portuguese Society of …

Objectives Introducing primary human papillomavirus (HPV) testing to cervical screening
programmes means changes to the results women receive. We explored additional …

Limited follow-up data are available on patients with cervical cytology results of atypical
squamous cells, cannot exclude a high-grade intraepithelial lesion (ASC-H), who test …

Objectives: The aim of this study was to conduct a review of health technology assessments
(HTAs) in cervical cancer screening to highlight the most common metrics HTA agencies use …

Objective To determine whether human papillomavirus (HPV) immunisation has affected the
prevalence of HPV genotypes and colposcopic features of cervical intraepithelial neoplasia …

Pap test, and especially HPV DNA test, identify a large group of women who do not have
any clinically relevant lesions, ie, CIN2+ (Cervical Intraepithelial Neoplasia grade 2 or …

Current cervical cancer screening programs are changing due to the development of tests
that detect the presence of human papillomavirus (HPV), the cause of cervical cancer. These …

In September 2017, the United States Preventive Services Task Force put forth updated draft
guidelines for cervical cancer screening in the United States, which were then open to public …